Literature DB >> 24237976

Sickle cell disease in childhood: from newborn screening through transition to adult medical care.

Charles T Quinn1.   

Abstract

Sickle cell disease (SCD) is the name for a group of related blood disorders caused by an abnormal hemoglobin molecule that polymerizes on deoxygenation. SCD affects the entire body, and the multisystem pathophysiology begins in infancy. Thanks to prognostic and therapeutic advancements, some forms of SCD-related morbidity are decreasing, such as overt stroke. Almost all children born with SCD in developed nations now live to adulthood, and lifelong multidisciplinary care is necessary. This article provides a broad overview of SCD in childhood, from newborn screening through transition to adult medical care.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diagnosis; Genetics; Pathophysiology; Sickle cell disease; Survival; Treatment

Mesh：

Year:  2013        PMID： 24237976      PMCID： PMC4262831          DOI： 10.1016/j.pcl.2013.09.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN： 0031-3955            Impact factor:   3.278


  33 in total

1.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Authors:  Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

2.  Increase in invasive Streptococcus pneumoniae infections in children with sickle cell disease since pneumococcal conjugate vaccine licensure.

Authors:  Timothy L McCavit; Charles T Quinn; Chonnamet Techasaensiri; Zora R Rogers
Journal:  J Pediatr       Date:  2010-12-28       Impact factor: 4.406

3.  Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure.

Authors:  Timothy L McCavit; Lei Xuan; Song Zhang; Glenn Flores; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2011-07-25       Impact factor: 3.167

4.  Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.

Authors:  Charles T Quinn; Marie J Stuart; Karen Kesler; Kenneth I Ataga; Winfred C Wang; Lori Styles; Kim Smith-Whitley; Ted Wun; Ashok Raj; Lewis L Hsu; Suba Krishnan; Frans A Kuypers; Yamaja Setty; Seungshin Rhee; Nigel S Key; George R Buchanan
Journal:  Br J Haematol       Date:  2011-08-16       Impact factor: 6.998

5.  Improved survival of children and adolescents with sickle cell disease.

Authors:  Charles T Quinn; Zora R Rogers; Timothy L McCavit; George R Buchanan
Journal:  Blood       Date:  2010-03-01       Impact factor: 22.113

6.  Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.

Authors:  Françoise Bernaudin; Suzanne Verlhac; Cécile Arnaud; Annie Kamdem; Sylvie Chevret; Isabelle Hau; Lena Coïc; Emmanuella Leveillé; Elisabeth Lemarchand; Emmanuelle Lesprit; Isabelle Abadie; Nadia Medejel; Fouad Madhi; Sophie Lemerle; Sandra Biscardi; Josiane Bardakdjian; Frédéric Galactéros; Martine Torres; Mathieu Kuentz; Christelle Ferry; Gérard Socié; Philippe Reinert; Christophe Delacourt
Journal:  Blood       Date:  2010-11-10       Impact factor: 22.113

Review 7.  Asthma and sickle cell disease: two distinct diseases or part of the same process?

Authors:  Joshua J Field; Michael R DeBaun
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2009

8.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

9.  Transient parvovirus-associated hypoplasia of multiple peripheral blood cell lines in children with chronic hemolytic anemia.

Authors:  Brian E Cauff; Charles T Quinn
Journal:  Pediatr Blood Cancer       Date:  2008-04       Impact factor: 3.167

10.  Sickle cell disease in children: differentiating osteomyelitis from vaso-occlusive crisis.

Authors:  Elizabeth Berger; Natasha Saunders; Lisa Wang; Jeremy N Friedman
Journal:  Arch Pediatr Adolesc Med       Date:  2009-03
View more
  27 in total

Review 1.  Current Standards of Care and Long Term Outcomes for Thalassemia and Sickle Cell Disease.

Authors:  Satheesh Chonat; Charles T Quinn
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

2.  Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

Authors:  B N Yamaja Setty; Suhita Gayen Betal; Robin E Miller; Dawn S Brown; Maureen Meier; Michele Cahill; Norma B Lerner; Nataly Apollonsky; Marie J Stuart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2019-05-10       Impact factor: 4.006

Review 3.  Novel insights in the management of sickle cell disease in childhood.

Authors:  Lorenzo Iughetti; Elena Bigi; Donatella Venturelli
Journal:  World J Clin Pediatr       Date:  2016-02-08

4.  The association between timely opioid administration and hospitalization in children with sickle cell disease presenting to the emergency department in acute pain.

Authors:  Cagla S Muslu; Matthew Kopetsky; Mark Nimmer; Alexis Visotcky; Raphael Fraser; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2020-07-02       Impact factor: 3.167

5.  Clinical Pathway for Vaso-Occlusive Pain Reduces Hospital Admissions.

Authors:  Wallace Jones; Albert Jang; Leann Myers; Aditi Dasgupta; Jessica DeBord
Journal:  J Healthc Qual       Date:  2022 Jan-Feb 01       Impact factor: 1.095

6.  Hemopexin dosing improves cardiopulmonary dysfunction in murine sickle cell disease.

Authors:  Paul W Buehler; Delaney Swindle; David I Pak; Scott K Ferguson; Susan M Majka; Vijaya Karoor; Radu Moldovan; Chantal Sintas; Jennifer Black; Thomas Gentinetta; Raphael M Buzzi; Florence Vallelian; Andreas Wassmer; Monika Edler; Joseph Bain; Daniel Schu; Kathryn Hassell; Rachelle Nuss; Dominik J Schaer; David C Irwin
Journal:  Free Radic Biol Med       Date:  2021-08-31       Impact factor: 8.101

7.  Disease Self-Efficacy and Health-Related Quality of Life in Adolescents With Sickle Cell Disease.

Authors:  Alana Goldstein-Leever; James L Peugh; Charles T Quinn; Lori E Crosby
Journal:  J Pediatr Hematol Oncol       Date:  2020-03       Impact factor: 1.170

8.  The invisibility of sickle cell disease in Brazil: lessons from a study in Maranhão.

Authors:  Marcos Borato Viana
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-20

Review 9.  A Meta-Analysis on the Seroprevalence of Parvovirus B19 among Patients with Sickle Cell Disease.

Authors:  Sagad Omer Obeid Mohamed; Esraa Mohamed Osman Mohamed; Afnan Abugundul Ahmed Osman; Fatima Abdelhakam Abdellatif MohamedElmugadam; Gehad Abdelmonem Abdalla Ibrahim
Journal:  Biomed Res Int       Date:  2019-12-09       Impact factor: 3.411

10.  Screening of Dry Blood Spots from Newborns by Two High Performance Liquid Chromatography (HPLC) Systems: A Comparison of Their Ability to Diagnose Both Sickle and Non-sickle Hemoglobinopathies.

Authors:  Manisha Ramani Daruwalla; Amar Das Gupta; Ravikiran Pawar
Journal:  Indian J Hematol Blood Transfus       Date:  2021-02-03       Impact factor: 0.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.